Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Cytokinetics (CYTK)

Cytokinetics (CYTK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,600,932
  • Shares Outstanding, K 59,470
  • Annual Sales, $ 26,870 K
  • Annual Income, $ -121,690 K
  • 60-Month Beta 1.44
  • Price/Sales 57.64
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.56
  • Number of Estimates 3
  • High Estimate -0.46
  • Low Estimate -0.61
  • Prior Year -0.56
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.20 +29.31%
on 06/12/20
27.47 -4.91%
on 07/09/20
+5.07 (+24.09%)
since 06/09/20
3-Month
13.08 +99.69%
on 04/15/20
27.47 -4.91%
on 07/09/20
+12.23 (+88.05%)
since 04/09/20
52-Week
7.72 +238.12%
on 11/08/19
27.47 -4.91%
on 07/09/20
+14.96 (+134.05%)
since 07/09/19

Most Recent Stories

More News
Cytokinetics to Host Virtual Investor & Analyst Day on July 15, 2020

Cytokinetics, Incorporated (Nasdaq: CYTK), today announced that it will host a Virtual Investor and Analyst Day on Wednesday, July 15, 2020 from 8:30 AM to 11:30 AM ET. Members of Cytokinetics' senior...

CYTK : 26.12 (-2.97%)
Interesting CYTK Put And Call Options For February 2021

Investors in Cytokinetics Inc saw new options begin trading this week, for the February 2021 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the...

CYTK : 26.12 (-2.97%)
Look for Shares of Cytokinetics Inc to Potentially Pullback after Yesterday's 2.02% Rise

Cytokinetics Inc (NASDAQ:CYTK) traded in a range yesterday that spanned from a low of $22.12 to a high of $23.11. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high...

CYTK : 26.12 (-2.97%)
Cytokinetics to Participate In Upcoming Investor Conferences

Cytokinetics, Incorporated (Nasdaq:CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a virtual fireside chat at the Goldman Sachs 41 Annual...

CYTK : 26.12 (-2.97%)
Uptrend Call Working As Cytokinetics Inc Stock Rises 86.2% (CYTK)

SmarTrend identified an Uptrend for Cytokinetics Inc (NASDAQ:CYTK) on March 27th, 2020 at $11.60. In approximately 2 months, Cytokinetics Inc has returned 86.20% as of today's recent price of $21.59.

CYTK : 26.12 (-2.97%)
Cytokinetics and The ALS Association Renew Partnership to Advance the Fight Against ALS

Cytokinetics, Incorporated (Nasdaq:CYTK) and The ALS Association today announced the continuation of their partnership in the fight against ALS. Cytokinetics is a sponsor of the 2020 ALS Roundtables and...

CYTK : 26.12 (-2.97%)
Look for Shares of Cytokinetics Inc to Potentially Pullback after Yesterday's 21.11% Rise

Cytokinetics Inc (NASDAQ:CYTK) traded in a range yesterday that spanned from a low of $18.43 to a high of $19.73. Yesterday, the shares gained 21.1%, which took the trading range above the 3-day high...

CYTK : 26.12 (-2.97%)
Thinking about buying stock in Aurora Cannabis, Cytokinetics, Quotient, Myriad Genetics, or Avaya Holdings?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ACB, CYTK, QTNT, MYGN, and AVYA.

ACB : 11.77 (-3.21%)
ACB.TO : 16.04 (-2.49%)
AVYA : 12.52 (+0.32%)
CYTK : 26.12 (-2.97%)
MYGN : 11.44 (-1.72%)
QTNT : 7.64 (+1.33%)
FDA Grants Fast Track Designation For Omecamtiv Mecarbil In Heart Failure

and SOUTH , /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Cytokinetics, Incorporated (NASDAQ:CYTK) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for omecamtiv...

AMGN : 251.66 (+0.03%)
CYTK : 26.12 (-2.97%)
Cytokinetics to Hold Annual Meeting of Stockholders

Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that its Annual Meeting of Stockholders will be held on Wednesday, May 13, 2020 at 10:30 AM Pacific Time at the Company's headquarters, 280 East...

CYTK : 26.12 (-2.97%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade CYTK with:

Business Summary

Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or deteriorating. With an unmatched understanding of muscle biology...

See More

Key Turning Points

2nd Resistance Point 28.15
1st Resistance Point 27.14
Last Price 26.12
1st Support Level 25.44
2nd Support Level 24.75

See More

52-Week High 27.47
Last Price 26.12
Fibonacci 61.8% 19.93
Fibonacci 50% 17.60
Fibonacci 38.2% 15.27
52-Week Low 7.72

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar